Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Inna Friesen
Observed names:
Friesen, Inna,
I Friesen,
I. Friesen,
Ina Friesen
Institution:
Research Center Borstel - Leibniz Lung Center
Observed institutions:
World Health Organization,
German Center for Infection Research,
Research Center Borstel - Leibniz Lung Center,
Charité – Universitätsmedizin Berlin
ORCID:
0000-0002-1374-6974
Observed ORCIDs:
0000-0002-1374-6974,
0000-0002-0489-2187
OpenAlex ID:
A5069347137
Long-term treatment outcomes in patients with multidrug-resistant tuberculosis
2023
·
Christina Maier
, Dumitru Chesov
, et al.
·
Clinical Microbiology and Infection
·
28
PDF
Clinical and genomic features of Mycobacterium avium complex: a multi-national European study
2024
·
Nils Wetzstein
, Margo Diricks
, et al.
·
Genome Medicine
·
23
Performance of the VITEK®2 advanced expert system™ for the validation of antimicrobial susceptibility testing results
2021
·
L Pages monteiro
, N. Von Allmen
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
20
Development of prevalence and incidence of non-tuberculous mycobacteria in German laboratories from 2016 to 2020
2023
·
Caroline Corbett
, Philipp Finger
, et al.
·
Emerging Microbes & Infections
·
19
PDF
A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis
2023
·
Niklas Köhler
, Hande Karaköse
, et al.
·
Pharmaceutics
·
14
PDF
Infektionsprävention & Hygiene bei Tuberkulose – Empfehlungen des DZK
2023
·
Peter Witte
, Mardjan Arvand
, et al.
·
Pneumologie
·
13
PDF
Therapie bei MDR-, prä-XDR-, XDR-Tuberkulose und Rifampicin-Resistenz oder bei Medikamentenunverträglichkeit gegenüber mindestens Rifampicin: Amendment vom 19.09.2023 zur S2k-Leitlinie: Tuberkulose im Erwachsenenalter des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose e. V. (DZK) im Auftrag der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP)
2023
·
Ralf Otto-Knapp
, Torsten Bauer
, et al.
·
Pneumologie
·
9
Bedaquiline, pretomanid and linezolid in multidrug-resistant and pre-extensively drug-resistant tuberculosis in refugees from Ukraine and Somalia in Germany
2024
·
Janina Trauth
, Vera Kantelhardt
, et al.
·
European Respiratory Journal
·
8
Genomic diversity and clinical relevance ofMycobacterium simiae
2024
·
Nils Wetzstein
, Margo Diricks
, et al.
·
ERJ Open Research
·
8
PDF
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland
2024
·
Ralf Otto-Knapp
, Torsten Bauer
, et al.
·
Respiration
·
6
PDF
Endocarditis associated with contamination of cardiovascular bioprostheses with Mycobacterium chelonae: a collaborative microbiological study
2024
·
Judith Kikhney
, Inna Friesen
, et al.
·
The Lancet Microbe
·
5
First detection of a Mycobacterium tuberculosis XDR clinical isolate harbouring an RpoB I491F mutation in a Ukrainian patient treated in Germany, October 2023
2024
·
Inna Friesen
, Viola Dreyer
, et al.
·
Eurosurveillance
·
5
PDF
Re: ‘Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe’ by Lange et al.
2024
·
Inna Friesen
, Francesca Saluzzo
, et al.
·
Clinical Microbiology and Infection
·
5
PDF
Whole genome sequence analysis reveals limited diversity among Clostridioides difficile ribotype 027 and 078 isolates collected in 22 hospitals in Berlin and Brandenburg, Germany
2025
·
Esther E. Dirks
, Vanessa Pfiffer
, et al.
·
Antimicrobial Resistance and Infection Control
·
4
PDF
Mycobacterium chelonae infection of a cardiovascular bioprosthesis linked to a recent outbreak
2025
·
Johanna Kessel
, Axel Braner
, et al.
·
Infection
·
3
PDF
Global lineages of non-tuberculous mycobacteria in residential water samples from Germany
2025
·
Margo Diricks
, Denia Frank
, et al.
·
BMC Microbiology
·
2
Active case finding for tuberculosis among Ukrainian soldiers by German armed forces
2025
·
Jessica Pohl
, Matthias I. Gröschel
, et al.
·
European Respiratory Journal
·
2
Understanding systematic rifampicin resistance errors with the FluoroType MTBDR VER 2.0
2025
·
D. Hillemann
, K. Schweim
, et al.
·
The International Journal of Tuberculosis and Lung Disease
·
2
Therapie der Tuberkulose: Was gibt es Neues?
2023
·
Thomas Theo Brehm
, Niklas Köhler
, et al.
·
Die Innere Medizin
·
2
Impact of an interdisciplinary standard operating procedure on external ventricular drainage-associated ventriculitis and antibiotic use in intensive care unit patients: a retrospective pre–post study
2026
·
Michaela Danassis
, Nilufar Akbari
, et al.
·
Journal of Anesthesia Analgesia and Critical Care
·
1
Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis
2024
·
A. Rauch
, N. Köhler
, et al.
·
Drugs
·
1
PDF
Update: Diagnostik und Therapie der pulmonalen Tuberkulose
2023
·
Inna Friesen
, Gunar Günther
, et al.
·
DMW - Deutsche Medizinische Wochenschrift
·
1
Comparative characteristics of the epidemiological situation of chemoresistant tuberculosis in Germany and Ukraine
2021
·
I. Friesen
, T. Ulrichs
, et al.
·
Tuberculosis Lung Diseases HIV Infection
·
1
Draft Genome Sequence of Mycobacteroides sp. Strain LB1, Isolated from the Sputum of a Cystic Fibrosis Patient
2020
·
Peter Menzel
, Rolf Schwarzer
, et al.
·
Microbiology Resource Announcements
·
1
Migration and tuberculosis transmission in Hamburg, Germany: insights from 25 years of molecular epidemiology
2026
·
Nicole Ullrich
, Roland Diel
, et al.
·
Genome Medicine
PDF
Show more works
View as search
Works count:
38
Citation count:
183
H-index:
8
I10-index:
6
Year
Topic
Type